指南与共识消化道肿瘤与早癌胃肠动力与功能性疾病

英国胃肠病学会实践指南:癌症治疗所致急性和慢性胃肠道症状与并发症的管理

British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer.
指南 / 共识 · Gut · 2025-06-06

该指南由多学科专家小组制定,采用BMJ AGREE II报告原则,共达成103条推荐,涵盖癌症治疗期间及之后出现的急性和慢性管腔胃肠道症状的评估、诊断与干预,强调患者视角、症状多重病因需全面诊断治疗,并指出无效或有疑问的检查与管理方法。

要点

  • 癌症治疗相关胃肠道副作用常见且困扰患者,可干扰治愈性治疗的实施。
  • 单一症状难以区分潜在病因,经验性治疗未快速显效时需进一步检查。
  • 患者常有多重胃肠道病因,需全部诊断并优化治疗才能缓解。

核心结论

  • 癌症治疗对个人、家庭和社会的躯体、情感和经济负担可能相当大。
  • 所有临床医生的职责是识别并引导需要专科服务的受影响患者。
  • 癌症治疗的进步日益要求患者在每个阶段获得专家、多学科支持性护理,提供有效且安全的治疗。
  • 应优先发展此类专长,并优先对卫生专业人员和公众开展关于急慢性胃肠道症状与并发症何时及如何管理的教育。

研究设计与样本

  • 多学科专家小组包括接受癌症治疗的患者,分组识别并综合管腔胃肠道副作用的评估、诊断和适当干预推荐。
  • 推荐采用BMJ AGREE II报告原则制定。

主要发现

  • 接受癌症治疗者中高达25%存在长期躯体副作用影响生活质量,胃肠道副作用最常见且最困扰。
  • 共达成103条推荐。
  • 单一症状或症状群难以区分潜在病因,经验性治疗未快速显著获益时需检查。
  • 患者常有多重胃肠道病因,均需诊断并优化治疗以实现缓解。

关键数值与推荐

  • 共达成103条推荐。
  • 接受癌症治疗者中高达25%存在长期躯体副作用影响生活质量,胃肠道副作用最常见且最困扰。

临床怎么用

  • 所有临床医生的职责是识别并引导需要专科服务的受影响患者。
  • 经验性治疗未快速显著获益时需进一步检查。
  • 患者常有多重胃肠道病因,均需诊断并优化治疗以实现缓解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Survival rates after a diagnosis of cancer are improving. Poorly managed gastrointestinal (GI) side effects can interfere with delivery of curative cancer treatment. Long-term physical side effects of cancer therapy impinge on quality of life in up to 25% of those treated for cancer, and GI side effects are the most common and troublesome. AIM: To provide comprehensive, practical guidance on the management of acute and chronic luminal gastrointestinal symptoms arising during and after treatment for cancer METHODS: A multidisciplinary expert group including patients treated for cancer, divided into working parties to identify, and synthesise recommendations for the optimal assessment, diagnosis and appropriate interventions for luminal GI side effects of systemic and local cancer therapies. Recommendations were developed using the principles of the BMJ AGREE II reporting. RESULTS: 103 recommendations were agreed. The importance of the patient perspective and what can be done to support patients are emphasised. Key physiological principles underlying the development of GI toxicity arising from cancer therapy are outlined. Individual symptoms or symptom clusters are poor at distinguishing the underlying cause(s), and investigations are required if empirical therapy does not lead rapidly to significant benefits. Patients frequently have multiple GI causes for symptoms; all need to be diagnosed and optimally treated to achieve resolution. Investigations and management approaches now known to be ineffective or of questionable benefit are highlighted. CONCLUSIONS: The physical, emotional and financial costs to individuals, their families and society from cancer therapy can be considerable. Identifying and signposting affected patients who require specialist services is the role of all clinicians. Progress in the treatment of cancer increasingly means that patients require expert, multidisciplinary supportive care providing effective and safe treatment at every stage of the cancer journey. Development of such expertise should be prioritised as should the education of health professionals and the public in what, when and how acute and chronic gastrointestinal symptoms and complications should be managed.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Andreyev J, Adams R, Bornschein J, et al. British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer. Gut. 2025. PMID: 40068855. doi:10.1136/gutjnl-2024-333812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。